Oppenheimer & Co »

Eliem Therapeutics shares owned by Oppenheimer & Co

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Oppenheimer & Co from 13F filings

Historical chart of Oppenheimer & Co investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Oppenheimer & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $541k 42k 13.04

More positions owned by Oppenheimer & Co

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Eli Lilly & Co. (LLY)
Costco Wholesale Corporation (COST)
Marvell Technology (MRVL)

View all positions for Oppenheimer & Co

Top funds holding Eliem Therapeutics

RA Capital Management
FMR
UBS Group
Braidwell
Adage Capital Partners GP
BlackRock
Cormorant Asset Management
Frontier Capital Management
T. Rowe Price Associates
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Redmile Group
Dr. Jeffrey R. Jay, M.D.
Affinity Asset Advisors

View all funds holding Eliem Therapeutics